Sage Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–May 8, 2018– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that members of the Sage management team will participate in a fireside chat presentation at the Bank